IL6 and lung carcinoma: In our study, we demonstrate that IL-6 could additionally alter the antitumor immune response through modulating DCs, since IL-6 secreted from lung cancer cell lines inhibited the IL-12p70 production from LPS-stimulated moDCs (Fig. 1).